Kevin Tan

Kevin Tan

Chief Financial OfficeratSolid Biosciences· In the 2023 proxy

Pay in FY2023Solid Biosciences stock +14.1% the same year

Kevin Tan was paid $1.3M in FY2023 (Dec). Solid Biosciences stock rose 14.1% that year.

Pay$100 in the stock at the end of FY22 → $114
Pay is from the Summary Compensation Table of each Solid Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Solid BiosciencesPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role +23%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?